Cargando…
How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890251/ https://www.ncbi.nlm.nih.gov/pubmed/35579627 http://dx.doi.org/10.1164/rccm.202204-0730ED |
| _version_ | 1784880910970126336 |
|---|---|
| author | Ben-Meir, Elad Grasemann, Hartmut |
| author_facet | Ben-Meir, Elad Grasemann, Hartmut |
| author_sort | Ben-Meir, Elad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9890251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98902512023-02-02 How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored? Ben-Meir, Elad Grasemann, Hartmut Am J Respir Crit Care Med Editorials American Thoracic Society 2022-05-17 /pmc/articles/PMC9890251/ /pubmed/35579627 http://dx.doi.org/10.1164/rccm.202204-0730ED Text en Copyright © 2022 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail Diane Gern (dgern@thoracic.org). |
| spellingShingle | Editorials Ben-Meir, Elad Grasemann, Hartmut How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored? |
| title | How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored? |
| title_full | How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored? |
| title_fullStr | How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored? |
| title_full_unstemmed | How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored? |
| title_short | How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored? |
| title_sort | how should the effects of cftr modulator therapy on cystic fibrosis lung disease be monitored? |
| topic | Editorials |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890251/ https://www.ncbi.nlm.nih.gov/pubmed/35579627 http://dx.doi.org/10.1164/rccm.202204-0730ED |
| work_keys_str_mv | AT benmeirelad howshouldtheeffectsofcftrmodulatortherapyoncysticfibrosislungdiseasebemonitored AT grasemannhartmut howshouldtheeffectsofcftrmodulatortherapyoncysticfibrosislungdiseasebemonitored |